Overview

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Patients will continue to use their current insulin pump for this study. Patients will receive insulin lispro and insulin aspart during this study. One medication will be taken for 12 weeks and then the other medication for 12 weeks. Neither the patient nor the study doctor will know which medication is being taken at any time. The order in which the two medications are taken will be determined by chance.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin Lispro
Insulin, Globin Zinc
Insulin, Long-Acting